Vladimir Brusic
Vladimir Brusic
Professor of Computing and Data Science, University of Nottingham Ningbo China
Verified email at
Cited by
Cited by
The transcriptional landscape of the mammalian genome
P Carninci, T Kasukawa, S Katayama, J Gough, MC Frith, N Maeda, ...
science 309 (5740), 1559-1563, 2005
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs
RIKEN Genome Exploration Research Group Phase I Team: Carninci P. 2 Hayatsu ...
Nature 420 (6915), 563-573, 2002
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
SA Shukla, MS Rooney, M Rajasagi, G Tiao, PM Dixon, MS Lawrence, ...
Nature biotechnology 33 (11), 1152-1158, 2015
Food authentication: Techniques, trends & emerging approaches
GP Danezis, AS Tsagkaris, F Camin, V Brusic, CA Georgiou
TrAC Trends in Analytical Chemistry 85, 123-132, 2016
Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research
HH Lin, S Ray, S Tongchusak, EL Reinherz, V Brusic
BMC immunology 9, 1-13, 2008
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
M Rajasagi, SA Shukla, EF Fritsch, DB Keskin, D DeLuca, E Carmona, ...
Blood 124 (3), 453-462, 2014
Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network.
V Brusic, G Rudy, G Honeyman, J Hammer, L Harrison
Bioinformatics (Oxford, England) 14 (2), 121-130, 1998
Molecular evolution and phylogeny of elapid snake venom three-finger toxins
BG Fry, W Wüster, RM Kini, V Brusic, A Khan, D Venkataraman, ...
Journal of molecular evolution 57, 110-129, 2003
HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane
ZYJ Sun, KJ Oh, M Kim, J Yu, V Brusic, L Song, Z Qiao, J Wang, ...
Immunity 28 (1), 52-63, 2008
MHCPEP, a database of MHC-binding peptides: update 1997
V Brusic, G Rudy, LC Harrison
Nucleic acids research 26 (1), 368-371, 1998
ANTIMIC: a database of antimicrobial sequences
M Brahmachary, SPT Krishnan, JLY Koh, AM Khan, SH Seah, TW Tan, ...
Nucleic acids research 32 (suppl_1), D586-D589, 2004
HLA-binding properties of tumor neoepitopes in humans
EF Fritsch, M Rajasagi, PA Ott, V Brusic, N Hacohen, CJ Wu
Cancer immunology research 2 (6), 522-529, 2014
Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets
AT Heiny, O Miotto, KN Srinivasan, AM Khan, GL Zhang, V Brusic, TW Tan, ...
PloS one 2 (11), e1190, 2007
Neural network-based prediction of candidate T-cell epitopes
MC Honeyman, V Brusic, NL Stone, LC Harrison
Nature biotechnology 16 (10), 966-969, 1998
Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications
V Brusic, VB Bajic, N Petrovsky
Methods 34 (4), 436-443, 2004
Melan-A/MART-151–73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells
HM Zarour, JM Kirkwood, LS Kierstead, W Herr, V Brusic, CL Slingluff Jr, ...
Proceedings of the National Academy of Sciences 97 (1), 400-405, 2000
Methods for prediction of peptide binding to MHC molecules: a comparative study
K Yu, N Petrovsky, C Schönbach, JLY Koh, V Brusic
Molecular medicine 8, 137-148, 2002
Food authentication: state of the art and prospects
GP Danezis, AS Tsagkaris, V Brusic, CA Georgiou
Current Opinion in Food Science 10, 22-31, 2016
MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides
GL Zhang, AM Khan, KN Srinivasan, JT August, V Brusic
Nucleic acids research 33 (suppl_2), W172-W179, 2005
NY-ESO-1 119–143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1-and Th2-type tumor-reactive CD4+ T cells
HM Zarour, B Maillere, V Brusic, K Coval, E Williams, S Pouvelle-Moratille, ...
Cancer research 62 (1), 213-218, 2002
The system can't perform the operation now. Try again later.
Articles 1–20